P A
Bluelighter
@Lolie
Interesting. That actually sounds like a remarkably efficient system, especially when compared to the one I've grown up with in the States. If you don't have damn good insurance around here, you're basically fucked if any significant health concerns (or general needs for pharmacotherapy) arise.
But many such drugs/indications - like thyroid hormone treatment in depressives - are decently well-backed by literally decades of research. And despite their comparatively sparse resources, independent research centers/hospitals do a good bulk of the research into 'off-label' indications, especially for those drugs whose profitable patents have expired in the U. S. and abroad (does the Commonwealth's system allow for patents, or is that system replaced in lieu by these 'subsidies?'). As such, I don't see what the drug companies have to do with it, since once a sufficient degree of patent protection is lost (in some statistically significant portion of paying countries), other drug companies sweep in to produce the generic counterparts. Or does that have no relevance to Australia's system?
I'm similarly confused as to how there could be such a thing as a brand label if the notion of a chemical patent is moot. This raises the question of how much relative profit a drug company could hope to incur in the first place by marketing drugs to what I assume is your federal government. In other words, what incentive could they possibly have? Much more money is to be made by marketing and selling newly developed medications to countries that allow market-cornering patents and direct purchase by sick consumers. Or does the government buy the drugs at some jacked-up 'patent' sum, then begin purchasing them at typical generic price at some specified year in the future? Are drug costs always the same for you, regardless of patent status abroad?
Confusing...
Interesting. That actually sounds like a remarkably efficient system, especially when compared to the one I've grown up with in the States. If you don't have damn good insurance around here, you're basically fucked if any significant health concerns (or general needs for pharmacotherapy) arise.
Many, many drugs are subsidised for off-label uses but getting new off-label uses approved for subsidy without significant research to back up such use is difficult. And drug companies don't want to run expensive trials to validate an off-label use for a relatively small market. Essentially they need to prove that their drug is both more effective and has less side effects than existing drugs which are subsidised for the same indication.
But many such drugs/indications - like thyroid hormone treatment in depressives - are decently well-backed by literally decades of research. And despite their comparatively sparse resources, independent research centers/hospitals do a good bulk of the research into 'off-label' indications, especially for those drugs whose profitable patents have expired in the U. S. and abroad (does the Commonwealth's system allow for patents, or is that system replaced in lieu by these 'subsidies?'). As such, I don't see what the drug companies have to do with it, since once a sufficient degree of patent protection is lost (in some statistically significant portion of paying countries), other drug companies sweep in to produce the generic counterparts. Or does that have no relevance to Australia's system?
I'm similarly confused as to how there could be such a thing as a brand label if the notion of a chemical patent is moot. This raises the question of how much relative profit a drug company could hope to incur in the first place by marketing drugs to what I assume is your federal government. In other words, what incentive could they possibly have? Much more money is to be made by marketing and selling newly developed medications to countries that allow market-cornering patents and direct purchase by sick consumers. Or does the government buy the drugs at some jacked-up 'patent' sum, then begin purchasing them at typical generic price at some specified year in the future? Are drug costs always the same for you, regardless of patent status abroad?
Confusing...
